CreditRiskMonitor is a financial risk analysis and news service for credit, supply chain and financial professionals.  Our strength in coverage spans 58,000 global public companies, totaling about $70 trillion in corporate revenue.  We also offer solutions that can help ease private company financial risk assessment.  Leading corporations around the world – including more than 35% of the Fortune 1000, plus thousands more worldwide – rely on us to help them stay ahead of financial risk quickly, accurately and cost-effectively. 

A partial report preview for Biocon Ltd is shown below.  Where indicated by "Yes," CreditRiskMonitor contains this information in its extensive database.  To get access to the full report and learn more about CreditRiskMonitor's robust financial risk analysis and timely news service, request a personalized demo and free trial today.

If you are already a subscriber and want to access the full report, click here.

Biocon Ltd
20th KM, Hosur Road, Electronic City,
Phone: +91 8028082808p:+91 8028082808 BANGALORE, 560100  India Ticker: BIOCONBIOCON
Business Summary
Biocon Limited is an India-based biopharmaceutical company, engaged in the manufacture of biotechnology products and research services. The Company is in the business of manufacturing active pharmaceutical ingredients (APIs) and formulations, including biosimilar drugs for diabetics, oncology and autoimmune diseases. The Company’s segment includes Generics, Biosimilars, Novel Biologics and Research Services. It focuses on three key therapeutic areas - Diabetes, Oncology and Immunology. Its APIs pipeline includes cardiovascular, anti-diabetics, immunosuppressants, and specialty molecules. Its products include Tacrolimus, Rosuvastatin, Simvastatin, Atorvastatin, Pravastatin, Fingolimod and others. Its APIs manufacturing facilities with capabilities in microbial fermentation, downstream process, including chromatographic purification, chemical synthesis, peptide synthesis and Highly Potent APIs (HPAPIs). It has over five facilities in Bangalore, Hyderabad and Visakhapatnam in India.

Scores and Ratings
FRISK®
Score		 Z''
Score		 PAYCE®
Score		 DBT
Index		 Moody's
Rating		 Fitch
Rating		 DBRS
Rating
YesYes-Yes---

Financials, News and Filings
Latest
Statement		 Last
Audit
News		 SEC
Filings		 Bankruptcy
Filings		 Suit &
Judgment
Filings		 Tax
Lien
Filings
9/30/20243/31/2024Yes----

Industries
SIC Code Description
2836 Biological products, except diagnostic substances
2834 Pharmaceutical preparations
8731 Commercial physical and biological research

Officers and Directors

Title
Name
Age		 Title
Date		 Start
Date
Executive Chairperson of the Board KiranMazumdarshaw 71 4/1/2020
Chief Executive Officer, Managing Director, Executive Director SiddharthMittal 46 4/1/2020 8/1/2014
Interim Chief Financial Officer MukeshKamath 6/11/2024 6/11/2024
12 additional Officers and Directors records available in full report.

Subsidiaries
Business Name Address City State/Province Country
Biocon Biologics UK Ltd 16 GREAT QUEEN STREET COVENT GARDEN United Kingdom
Biocon Pharma Ltd. 20th KM, Hosur Road, Electronics City BANGALORE India
BIOCON BIOLOGICS INDIA LIMITED BIOCON HOUSE, GROUND FLOOR,TOWER-3, SEMICON PARK,ELECTRONIC KARNATAKA INDIA
Biocon Biologics Ltd Biocon House, Semicon Park Karnataka India

Business Names
Business Name
532523
BIOCON
BIOCON BIOLOGICS UK LIMITED
Biocon Limited

General Information
Number of Employees: 3,681 (As of 3/31/2024)
Outstanding Shares: 1,200,600,000 (As of 9/30/2024)
Shareholders: 470,261
Stock Exchange: NSE
Fax Number: +91 8028523423


Copyright © 2024 CreditRiskMonitor.com (Ticker: CRMZ). All rights reserved.     
By using this website, you accept the Terms of Use Agreement.
Monday, December 2, 2024